Suggestions
David Stone
Head of Genetics at Cerevel Therapeutics, LLC
Professional Background
David Stone is a highly accomplished neuroscientist and geneticist, boasting an impressive 20 years of experience in the biotechnology and pharmaceutical industries, along with 5 years of service in academia. Currently, he holds the esteemed position of Head of Genetics at Cerevel Therapeutics, LLC, where he leads innovative research efforts in genetic science and drug development aimed at treating neurological disorders.
Before joining Cerevel Therapeutics, David made significant contributions at Merck, where he served in multiple roles, including Director of Neurogenetics, Director of Genetics, and Director of Molecular Profiling Neuroscience. During his tenure at Merck, he was instrumental in drug target and biomarker discovery, pioneering efforts that have shaped current understanding in neuroscience and genetics. His experience also encompasses being a Research Fellow at Merck, where he further developed his skills in molecular biology, neuroscience, and statistical analysis.
Additionally, David worked at CuraGen Corporation as a Project Leader, applying his expertise in high-throughput screening to advance genetic research and pharmaceutical development. His academic journey includes impactful roles, such as serving as an Instructor in the Department of Psychiatry at Harvard Medical School, where he contributed to both teaching and research within the field of neurobiology.
Education and Achievements
David's academic journey is rooted in a strong background in genetics and biology. He completed his Ph.D. in Anthropology with a focus on Population Genetics at the respected University of Pittsburgh. This educational foundation has equipped him with in-depth knowledge of genetic variability and its implications in various biological contexts.
Prior to his doctoral studies, David pursued a Master's degree in Education at the University of Pittsburgh, enhancing his understanding of pedagogical methods alongside his scientific training. Furthermore, he earned a Bachelor of Science degree in Biology from Saint Vincent College, where he first ignited his passion for the life sciences and the intricacies of genetic research.
Throughout his career, David has amassed a wealth of knowledge and expertise, particularly in molecular biology, neuroscience, genetics/genomics, and statistical analysis. His proficiency in high-throughput screening has made him a pivotal figure in the discovery and development of novel therapeutic targets, particularly in the context of neurological disorders.
David’s professional journey is not only defined by his roles in the industry but also by his commitment to advancing the field of genetics through research and mentorship. At Harvard Medical School, he inspired the next generation of scientists, fostering an environment of curiosity and innovation.
Achievements
David Stone's career is replete with notable achievements that underline his expertise and commitment to neuroscience and genetics. His leadership at Cerevel Therapeutics signifies his dedication to pushing the boundaries of genetic research in neurology. At Merck, his directorship roles enabled significant advancements in drug development processes, leading to breakthroughs in neurogenetics that have benefitted countless patients.
Moreover, David's extensive publication record reflects his contributions to scientific knowledge. His work has been featured in reputable journals, further solidifying his status as a thought leader in the field. David's insights and discoveries have not only advanced academic understanding but have also translated into real-world applications in therapeutic strategies, thereby improving the quality of life for those suffering from neurological conditions.
With a robust combination of academic prowess, extensive industry experience, and a commitment to educating future scientists, David Stone continues to be a prominent figure in the realms of neuroscience and genetics. His work ensures that the next generations will benefit from innovative treatments that stem from rigorous scientific inquiry and discovery.